Article
Genome-wide association study: Exploring the genetic basis for responsiveness to ketogenic dietary therapies for drug-resistant epilepsy.
Epilepsia - 1 Aug 2018
Schoeler Natasha E, Leu Costin, Balestrini Simona, Mudge Jonathan M, Steward Charles A, Frankish Adam, Leung Mary-Anne, Mackay Mark, Scheffer Ingrid, Williams Ruth, Sander Josemir W, Cross J Helen, Sisodiya Sanjay M
Abstract excerpt
OBJECTIVE: With the exception of specific metabolic disorders, predictors of response to ketogenic dietary therapies (KDTs) are unknown. We aimed to determine whether common variation across the genome influences the response to KDT for epilepsy. METHODS: We genotyped individuals who were negative for glucose transporter type 1 deficiency syndrome or other metabolic disorders, who received KDT for epilepsy....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
